| Product Code: ETC12466927 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
In 2024, Israel`s import of immunotoxins continued to be dominated by key exporters such as Switzerland, Germany, USA, Belgium, and China. The high concentration levels, as indicated by the HHI, suggest a competitive market among these top exporting countries. Despite a negative CAGR from 2020 to 2024, there was a notable growth spike in 2024 with a 12.72% increase from the previous year. This indicates potential opportunities for market expansion and increased demand for immunotoxins in Israel, pointing towards a positive trend in the sector.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Immunotoxins Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Immunotoxins Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Immunotoxins Market - Industry Life Cycle |
3.4 Israel Immunotoxins Market - Porter's Five Forces |
3.5 Israel Immunotoxins Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Israel Immunotoxins Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Israel Immunotoxins Market Revenues & Volume Share, By Target Cell, 2021 & 2031F |
3.8 Israel Immunotoxins Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Israel Immunotoxins Market Revenues & Volume Share, By Sales Channel, 2021 & 2031F |
4 Israel Immunotoxins Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Israel, leading to a higher demand for immunotoxins as a targeted therapy. |
4.2.2 Growing investments in research and development of immunotoxin therapies in Israel. |
4.2.3 Favorable government initiatives and policies supporting the development and commercialization of immunotoxins in the country. |
4.3 Market Restraints |
4.3.1 High cost associated with the development and production of immunotoxins, impacting affordability and accessibility. |
4.3.2 Stringent regulatory requirements for the approval and commercialization of immunotoxin therapies in Israel. |
5 Israel Immunotoxins Market Trends |
6 Israel Immunotoxins Market, By Types |
6.1 Israel Immunotoxins Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Immunotoxins Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Israel Immunotoxins Market Revenues & Volume, By Ricin-Based, 2021 - 2031F |
6.1.4 Israel Immunotoxins Market Revenues & Volume, By Pseudomonas Exotoxin-Based, 2021 - 2031F |
6.1.5 Israel Immunotoxins Market Revenues & Volume, By Diphtheria Toxin-Based, 2021 - 2031F |
6.1.6 Israel Immunotoxins Market Revenues & Volume, By Antibody-Drug Conjugates, 2021 - 2031F |
6.2 Israel Immunotoxins Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Israel Immunotoxins Market Revenues & Volume, By Cancer Therapy, 2021 - 2031F |
6.2.3 Israel Immunotoxins Market Revenues & Volume, By Autoimmune Diseases, 2021 - 2031F |
6.2.4 Israel Immunotoxins Market Revenues & Volume, By Infectious Diseases, 2021 - 2031F |
6.2.5 Israel Immunotoxins Market Revenues & Volume, By Neurological Disorders, 2021 - 2031F |
6.3 Israel Immunotoxins Market, By Target Cell |
6.3.1 Overview and Analysis |
6.3.2 Israel Immunotoxins Market Revenues & Volume, By Leukemia Cells, 2021 - 2031F |
6.3.3 Israel Immunotoxins Market Revenues & Volume, By Lymphoma Cells, 2021 - 2031F |
6.3.4 Israel Immunotoxins Market Revenues & Volume, By Breast Cancer Cells, 2021 - 2031F |
6.3.5 Israel Immunotoxins Market Revenues & Volume, By Tumor Cells, 2021 - 2031F |
6.4 Israel Immunotoxins Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Israel Immunotoxins Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 Israel Immunotoxins Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.4.4 Israel Immunotoxins Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.4.5 Israel Immunotoxins Market Revenues & Volume, By Pharma Companies, 2021 - 2031F |
6.5 Israel Immunotoxins Market, By Sales Channel |
6.5.1 Overview and Analysis |
6.5.2 Israel Immunotoxins Market Revenues & Volume, By Direct Sales, 2021 - 2031F |
6.5.3 Israel Immunotoxins Market Revenues & Volume, By Distributors, 2021 - 2031F |
6.5.4 Israel Immunotoxins Market Revenues & Volume, By Online Platforms, 2021 - 2031F |
6.5.5 Israel Immunotoxins Market Revenues & Volume, By Hospital Suppliers, 2021 - 2031F |
7 Israel Immunotoxins Market Import-Export Trade Statistics |
7.1 Israel Immunotoxins Market Export to Major Countries |
7.2 Israel Immunotoxins Market Imports from Major Countries |
8 Israel Immunotoxins Market Key Performance Indicators |
8.1 Number of clinical trials involving immunotoxin therapies conducted in Israel. |
8.2 Amount of funding allocated to Israeli companies for the development of immunotoxin therapies. |
8.3 Adoption rate of immunotoxin therapies in clinical settings in Israel. |
8.4 Number of partnerships and collaborations between Israeli biotech companies and international pharmaceutical firms in the field of immunotoxins. |
8.5 Success rate of Israeli companies in obtaining regulatory approvals for their immunotoxin products. |
9 Israel Immunotoxins Market - Opportunity Assessment |
9.1 Israel Immunotoxins Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Israel Immunotoxins Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Israel Immunotoxins Market Opportunity Assessment, By Target Cell, 2021 & 2031F |
9.4 Israel Immunotoxins Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 Israel Immunotoxins Market Opportunity Assessment, By Sales Channel, 2021 & 2031F |
10 Israel Immunotoxins Market - Competitive Landscape |
10.1 Israel Immunotoxins Market Revenue Share, By Companies, 2024 |
10.2 Israel Immunotoxins Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here